Report Cover

Global Biosimilar Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027


Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original ???innovator??? products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent. 
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

Market Analysis and Insights: Global Biosimilar Drug Market
In 2020, the global Biosimilar Drug market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
Global Biosimilar Drug Scope and Market Size
Biosimilar Drug market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Biosimilar Drug market is segmented into
    Injection
    Tablets
    Other Types

Segment by Application, the Biosimilar Drug market is segmented into
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Regional and Country-level Analysis:
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Southeast Asia
        Australia
        Rest of Asia-Pacific
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Competitive Landscape and Biosimilar Drug Market Share Analysis
Biosimilar Drug market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Biosimilar Drug product introduction, recent developments, Biosimilar Drug sales by region, type, application and by sales channel.

The major companies include:
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius
    Amgen
    Eli Lilly
    Sandoz
    Changchun High Tech
    Innovent
1 Study Coverage
    1.1 Biosimilar Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type
        1.2.2 Injection
        1.2.3 Tablets
        1.2.4 Other Types
    1.3 Market by Application
        1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application
        1.3.2 Ankylosing Spondylitis
        1.3.3 Tumor
        1.3.4 Rheumatoid Arthrtis
        1.3.5 Cardiovascular
        1.3.6 Other Application
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Biosimilar Drug Market Size Estimates and Forecasts
        2.1.1 Global Biosimilar Drug Revenue 2016-2027
        2.1.2 Global Biosimilar Drug Sales 2016-2027
    2.2 Biosimilar Drug Market Size by Region: 2021 Versus 2027
    2.3 Biosimilar Drug Sales by Region (2016-2027)
        2.3.1 Global Biosimilar Drug Sales by Region: 2016-2021
        2.3.2 Global Biosimilar Drug Sales Forecast by Region (2022-2027)
        2.3.3 Global Biosimilar Drug Sales Market Share by Region (2016-2027)
    2.4 Biosimilar Drug Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Biosimilar Drug Revenue by Region: 2016-2021
        2.4.2 Global Biosimilar Drug Revenue Forecast by Region (2022-2027)
        2.4.3 Global Biosimilar Drug Revenue Market Share by Region (2016-2027)

3 Global Biosimilar Drug by Manufacturers
    3.1 Global Top Biosimilar Drug Manufacturers by Sales
        3.1.1 Global Biosimilar Drug Sales by Manufacturer (2016-2021)
        3.1.2 Global Biosimilar Drug Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Biosimilar Drug Manufacturers by Revenue
        3.2.1 Global Biosimilar Drug Revenue by Manufacturer (2016-2021)
        3.2.2 Global Biosimilar Drug Revenue Share by Manufacturer (2016-2021)
    3.3 Global Biosimilar Drug Price by Manufacturer (2016-2021)
    3.4 Competitive Landscape
        3.4.1 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
        3.4.2 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) & (2016-2021)
        3.4.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.5 Global Biosimilar Drug Manufacturing Base Distribution, Product Type
        3.5.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.5.2 Manufacturers Biosimilar Drug Product Type
        3.5.3 Date of International Manufacturers Enter into Biosimilar Drug Market
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
    4.1 CP Guojian Pharma
        4.1.1 CP Guojian Pharma Corporation Information
        4.1.2 CP Guojian Pharma Description, Business Overview
        4.1.3 CP Guojian Pharma Biosimilar Drug Products Offered
        4.1.4 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.1.5 CP Guojian Pharma Biosimilar Drug Revenue by Product
        4.1.6 CP Guojian Pharma Biosimilar Drug Revenue by Application
        4.1.7 CP Guojian Pharma Biosimilar Drug Revenue by Geographic Area
        4.1.8 CP Guojian Pharma Biosimilar Drug Revenue by Sales Channel
        4.1.9 CP Guojian Pharma Recent Development
    4.2 Biotech Pharma
        4.2.1 Biotech Pharma Corporation Information
        4.2.2 Biotech Pharma Description, Business Overview
        4.2.3 Biotech Pharma Biosimilar Drug Products Offered
        4.2.4 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.2.5 Biotech Pharma Biosimilar Drug Revenue by Product
        4.2.6 Biotech Pharma Biosimilar Drug Revenue by Application
        4.2.7 Biotech Pharma Biosimilar Drug Revenue by Geographic Area
        4.2.8 Biotech Pharma Biosimilar Drug Revenue by Sales Channel
        4.2.9 Biotech Pharma Recent Development
    4.3 Celgen Pharma
        4.3.1 Celgen Pharma Corporation Information
        4.3.2 Celgen Pharma Description, Business Overview
        4.3.3 Celgen Pharma Biosimilar Drug Products Offered
        4.3.4 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.3.5 Celgen Pharma Biosimilar Drug Revenue by Product
        4.3.6 Celgen Pharma Biosimilar Drug Revenue by Application
        4.3.7 Celgen Pharma Biosimilar Drug Revenue by Geographic Area
        4.3.8 Celgen Pharma Biosimilar Drug Revenue by Sales Channel
        4.3.9 Celgen Pharma Recent Development
    4.4 Henlius
        4.4.1 Henlius Corporation Information
        4.4.2 Henlius Description, Business Overview
        4.4.3 Henlius Biosimilar Drug Products Offered
        4.4.4 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.4.5 Henlius Biosimilar Drug Revenue by Product
        4.4.6 Henlius Biosimilar Drug Revenue by Application
        4.4.7 Henlius Biosimilar Drug Revenue by Geographic Area
        4.4.8 Henlius Biosimilar Drug Revenue by Sales Channel
        4.4.9 Henlius Recent Development
    4.5 Amgen
        4.5.1 Amgen Corporation Information
        4.5.2 Amgen Description, Business Overview
        4.5.3 Amgen Biosimilar Drug Products Offered
        4.5.4 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.5.5 Amgen Biosimilar Drug Revenue by Product
        4.5.6 Amgen Biosimilar Drug Revenue by Application
        4.5.7 Amgen Biosimilar Drug Revenue by Geographic Area
        4.5.8 Amgen Biosimilar Drug Revenue by Sales Channel
        4.5.9 Amgen Recent Development
    4.6 Eli Lilly
        4.6.1 Eli Lilly Corporation Information
        4.6.2 Eli Lilly Description, Business Overview
        4.6.3 Eli Lilly Biosimilar Drug Products Offered
        4.6.4 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.6.5 Eli Lilly Biosimilar Drug Revenue by Product
        4.6.6 Eli Lilly Biosimilar Drug Revenue by Application
        4.6.7 Eli Lilly Biosimilar Drug Revenue by Geographic Area
        4.6.8 Eli Lilly Recent Development
    4.7 Sandoz
        4.7.1 Sandoz Corporation Information
        4.7.2 Sandoz Description, Business Overview
        4.7.3 Sandoz Biosimilar Drug Products Offered
        4.7.4 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.7.5 Sandoz Biosimilar Drug Revenue by Product
        4.7.6 Sandoz Biosimilar Drug Revenue by Application
        4.7.7 Sandoz Biosimilar Drug Revenue by Geographic Area
        4.7.8 Sandoz Recent Development
    4.8 Changchun High Tech
        4.8.1 Changchun High Tech Corporation Information
        4.8.2 Changchun High Tech Description, Business Overview
        4.8.3 Changchun High Tech Biosimilar Drug Products Offered
        4.8.4 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.8.5 Changchun High Tech Biosimilar Drug Revenue by Product
        4.8.6 Changchun High Tech Biosimilar Drug Revenue by Application
        4.8.7 Changchun High Tech Biosimilar Drug Revenue by Geographic Area
        4.8.8 Changchun High Tech Recent Development
    4.9 Innovent
        4.9.1 Innovent Corporation Information
        4.9.2 Innovent Description, Business Overview
        4.9.3 Innovent Biosimilar Drug Products Offered
        4.9.4 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
        4.9.5 Innovent Biosimilar Drug Revenue by Product
        4.9.6 Innovent Biosimilar Drug Revenue by Application
        4.9.7 Innovent Biosimilar Drug Revenue by Geographic Area
        4.9.8 Innovent Recent Development

5 Breakdown Data by Type
    5.1 Global Biosimilar Drug Sales by Type (2016-2027)
        5.1.1 Global Biosimilar Drug Sales by Type (2016-2021)
        5.1.2 Global Biosimilar Drug Sales Forecast by Type (2022-2027)
        5.1.3 Global Biosimilar Drug Sales Market Share by Type (2016-2027)
    5.2 Global Biosimilar Drug Revenue Forecast by Type (2016-2027)
        5.2.1 Global Biosimilar Drug Revenue by Type (2016-2021)
        5.2.2 Global Biosimilar Drug Revenue Forecast by Type (2022-2027)
        5.2.3 Global Biosimilar Drug Revenue Market Share by Type (2016-2027)
    5.3 Biosimilar Drug Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application
    6.1 Global Biosimilar Drug Sales by Application (2016-2027)
        6.1.1 Global Biosimilar Drug Sales by Application (2016-2021)
        6.1.2 Global Biosimilar Drug Sales Forecast by Application (2022-2027)
        6.1.3 Global Biosimilar Drug Sales Market Share by Application (2016-2027)
    6.2 Global Biosimilar Drug Revenue Forecast by Application (2016-2027)
        6.2.1 Global Biosimilar Drug Revenue by Application (2016-2021)
        6.2.2 Global Biosimilar Drug Revenue Forecast by Application (2022-2027)
        6.2.3 Global Biosimilar Drug Revenue Market Share by Application (2016-2027)
    6.3 Biosimilar Drug Average Selling Price (ASP) by Application (2016-2027)

7 North America
    7.1 North America Biosimilar Drug Market Size YoY Growth 2016-2027
    7.2 North America Biosimilar Drug Market Facts & Figures by Country
        7.2.1 North America Biosimilar Drug Sales by Country (2016-2027)
        7.2.2 North America Biosimilar Drug Revenue by Country (2016-2027)
    7.3 North America Biosimilar Drug Sales by Type
    7.4 North America Biosimilar Drug Sales by Application

8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Drug Market Size YoY Growth 2016-2027
    8.2 Asia-Pacific Biosimilar Drug Market Facts & Figures by Region
        8.2.1 Asia-Pacific Biosimilar Drug Sales by Region (2016-2027)
        8.2.2 Asia-Pacific Biosimilar Drug Revenue by Region (2016-2027)
    8.3 Asia-Pacific Biosimilar Drug Sales by Type
    8.4 Asia-Pacific Biosimilar Drug Sales by Application

9 Europe
    9.1 Europe Biosimilar Drug Market Size YoY Growth 2016-2027
    9.2 Europe Biosimilar Drug Market Facts & Figures by Country
        9.2.1 Europe Biosimilar Drug Sales by Country (2016-2027)
        9.2.2 Europe Biosimilar Drug Revenue by Country (2016-2027)
    9.3 Europe Biosimilar Drug Sales by Type
    9.4 Europe Biosimilar Drug Sales by Application

10 Latin America
    10.1 Latin America Biosimilar Drug Market Size YoY Growth 2016-2027
    10.2 Latin America Biosimilar Drug Market Facts & Figures by Country
        10.2.1 Latin America Biosimilar Drug Sales by Country (2016-2027)
        10.2.2 Latin America Biosimilar Drug Revenue by Country (2016-2027)
    10.3 Latin America Biosimilar Drug Sales by Type
    10.4 Latin America Biosimilar Drug Sales by Application

11 Middle East and Africa
    11.1 Middle East and Africa Biosimilar Drug Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Biosimilar Drug Sales by Country (2016-2027)
        11.2.2 Middle East and Africa Biosimilar Drug Revenue by Country (2016-2027)
    11.3 Middle East and Africa Biosimilar Drug Sales by Type
    11.4 Middle East and Africa Biosimilar Drug Sales by Application

12 Supply Chain and Sales Channel Analysis
    12.1 Biosimilar Drug Supply Chain Analysis
    12.2 Biosimilar Drug Key Raw Materials and Upstream Suppliers
    12.3 Biosimilar Drug Clients Analysis
    12.4 Biosimilar Drug Sales Channel and Sales Model Analysis
        12.4.1 Biosimilar Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
        12.4.2 Biosimilar Drug Distribution Channel Analysis: Online Sales VS Offline Sales
        12.4.3 Biosimilar Drug Distributors

13 Market Dynamics
    13.1 Biosimilar Drug Market Drivers
    13.2 Biosimilar Drug Market Opportunities
    13.3 Biosimilar Drug Market Challenges
    13.4 Biosimilar Drug Market Restraints
    13.5 Porter's Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Biosimilar Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2027 Table 2. Major Manufacturers of Injection Table 3. Major Manufacturers of Tablets Table 4. Major Manufacturers of Other Types Table 5. Global Biosimilar Drug Market Size Growth by Application (US$ Million): 2021 VS 2027 Table 6. Global Biosimilar Drug Market Size by Region (US$ Million): 2021 VS 2027 Table 7. Global Biosimilar Drug Sales by Region (2016-2021) & (K Dose) Table 8. Global Biosimilar Drug Sales Forecast by Region (2022-2027) & (K Dose) Table 9. Global Biosimilar Drug Revenue by Region (2016-2021) & (US$ Million) Table 10. Global Biosimilar Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 11. Global Biosimilar Drug Sales by Manufacturer (2016-2021) & (K Dose) Table 12. Global Biosimilar Drug Sales Share by Manufacturer (2016-2021) Table 13. Biosimilar Drug Revenue by Manufacturer (2016-2021) & (US$ Million) Table 14. Biosimilar Drug Revenue Share by Manufacturer (2016-2021) Table 15. Key Manufacturers Biosimilar Drug Price (2016-2021) & (USD/Dose) Table 16. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2020 Table 17. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 18. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2020) Table 19. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Biosimilar Drug Product Type Table 21. Date of International Manufacturers Enter into Biosimilar Drug Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. CP Guojian Pharma Corporation Information Table 24. CP Guojian Pharma Description and Business Overview Table 25. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 26. CP Guojian Pharma Biosimilar Drug Product Table 27. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 28. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 29. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 30. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel Table 31. CP Guojian Pharma Recent Development Table 32. Biotech Pharma Corporation Information Table 33. Biotech Pharma Description and Business Overview Table 34. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 35. Biotech Pharma Biosimilar Drug Product Table 36. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 37. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 38. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 39. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel Table 40. Biotech Pharma Recent Development Table 41. Celgen Pharma Corporation Information Table 42. Celgen Pharma Description and Business Overview Table 43. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 44. Celgen Pharma Biosimilar Drug Product Table 45. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 46. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 47. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 48. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel Table 49. Celgen Pharma Recent Development Table 50. Henlius Corporation Information Table 51. Henlius Description and Business Overview Table 52. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 53. Henlius Biosimilar Drug Product Table 54. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 55. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 56. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 57. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel Table 58. Henlius Recent Development Table 59. Amgen Corporation Information Table 60. Amgen Description and Business Overview Table 61. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 62. Amgen Biosimilar Drug Product Table 63. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 64. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 65. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 66. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel Table 67. Amgen Recent Development Table 68. Eli Lilly Corporation Information Table 69. Eli Lilly Description and Business Overview Table 70. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 71. Eli Lilly Biosimilar Drug Product Table 72. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 73. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 74. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 75. Eli Lilly Recent Development Table 76. Sandoz Corporation Information Table 77. Sandoz Description and Business Overview Table 78. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 79. Sandoz Biosimilar Drug Product Table 80. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 81. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 82. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 83. Sandoz Recent Development Table 84. Changchun High Tech Corporation Information Table 85. Changchun High Tech Description and Business Overview Table 86. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 87. Changchun High Tech Biosimilar Drug Product Table 88. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 89. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 90. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 91. Changchun High Tech Recent Development Table 92. Innovent Corporation Information Table 93. Innovent Description and Business Overview Table 94. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 95. Innovent Biosimilar Drug Product Table 96. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Product Table 97. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Application Table 98. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area Table 99. Innovent Recent Development Table 100. Global Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 101. Global Biosimilar Drug Sales Forecast by Type (2022-2027) & (K Dose) Table 102. Global Biosimilar Drug Revenue by Type (2016-2021) & (US$ Million) Table 103. Global Biosimilar Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 104. Global Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 105. Global Biosimilar Drug Sales Forecast by Application (2022-2027) & (K Dose) Table 106. Global Biosimilar Drug Revenue by Application (2016-2021) & (US$ Million) Table 107. Global Biosimilar Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 108. North America Biosimilar Drug Sales by Country (2016-2021) & (K Dose) Table 109. North America Biosimilar Drug Sales by Country (2022-2027) & (K Dose) Table 110. North America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million) Table 111. North America Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million) Table 112. North America Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 113. North America Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 114. Asia-Pacific Biosimilar Drug Sales by Region (2016-2021) & (K Dose) Table 115. Asia-Pacific Biosimilar Drug Sales by Region (2022-2027) & (K Dose) Table 116. Asia-Pacific Biosimilar Drug Revenue by Region (2016-2027) & (US$ Million) Table 117. Asia-Pacific Biosimilar Drug Revenue by Region (2022-2027) & (US$ Million) Table 118. Asia-Pacific Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 119. Asia-Pacific Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 120. Europe Biosimilar Drug Sales by Country (2016-2021) & (K Dose) Table 121. Europe Biosimilar Drug Sales by Country (2022-2027) & (K Dose) Table 122. Europe Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million) Table 123. Europe Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million) Table 124. Europe Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 125. Europe Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 126. Latin America Biosimilar Drug Sales by Country (2016-2021) & (K Dose) Table 127. Latin America Biosimilar Drug Sales by Country (2022-2027) & (K Dose) Table 128. Latin America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million) Table 129. Latin America Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million) Table 130. Latin America Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 131. Latin America Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 132. Middle East and Africa Biosimilar Drug Sales by Country (2016-2021) & (K Dose) Table 133. Middle East and Africa Biosimilar Drug Sales by Country (2022-2027) & (K Dose) Table 134. Middle East and Africa Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million) Table 135. Middle East and Africa Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million) Table 136. Middle East and Africa Biosimilar Drug Sales by Type (2016-2021) & (K Dose) Table 137. Middle East and Africa Biosimilar Drug Sales by Application (2016-2021) & (K Dose) Table 138. Biosimilar Drug Key Raw Materials, Industry Status and Trend Table 139. Biosimilar Drug Key Raw Materials and Upstream Suppliers Table 140. Biosimilar Drug Clients Status and Trend Table 141. Biosimilar Drug Typical Clients Table 142. Biosimilar Drug Distributors Table 143. Key Drivers: Impact Analysis (2022-2027) Table 144. Biosimilar Drug Market Drivers Table 145. Biosimilar Drug Market Opportunities Table 146. Biosimilar Drug Market Challenges Table 147. Biosimilar Drug Market Restraints Table 148. Biosimilar Drug Porter's Five Forces Analysis Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Biosimilar Drug Product Picture Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2021 & 2027 Figure 3. Injection Product Picture Figure 4. Tablets Product Picture Figure 5. Other Types Product Picture Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2021 & 2027 Figure 7. Ankylosing Spondylitis Examples Figure 8. Tumor Examples Figure 9. Rheumatoid Arthrtis Examples Figure 10. Cardiovascular Examples Figure 11. Other Application Examples Figure 12. Biosimilar Drug Report Years Considered Figure 13. Global Biosimilar Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Biosimilar Drug Market Size 2016-2027 (US$ Million) Figure 15. Global Biosimilar Drug Sales 2016-2027 (K Units) Figure 16. Global Biosimilar Drug Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Biosimilar Drug Sales Market Share Forecast by Region (2016-2027) Figure 18. Global Biosimilar Drug Revenue Market Share by Region (2016-2027) Figure 19. Global Biosimilar Drug Sales Share by Manufacturer in 2020 Figure 20. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Biosimilar Drug Sales Market Share Forecast by Type (2016-2027) Figure 22. Global Biosimilar Drug Revenue Market Share Forecast by Type (2016-2027) Figure 23. Biosimilar Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Figure 24. Global Biosimilar Drug Sales Market Share Forecast by Application (2016-2027) Figure 25. Global Biosimilar Drug Revenue Market Share Forecast by Application (2016-2027) Figure 26. Biosimilar Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Figure 27. North America Biosimilar Drug Revenue 2016-2027 (US$ Million) Figure 28. North America Biosimilar Drug Sales Market Share by Type (2016-2021) Figure 29. North America Biosimilar Drug Sales Market Share by Application (2016-2021) Figure 30. Asia-Pacific Biosimilar Drug Revenue 2016-2027 (US$ Million) Figure 31. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2027) Figure 32. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2016-2027) Figure 33. Asia-Pacific Biosimilar Drug Sales Market Share by Type (2016-2021) Figure 34. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2016-2021) Figure 35. Europe Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million) Figure 36. Europe Biosimilar Drug Sales Market Share by Country (2016-2027) Figure 37. Europe Biosimilar Drug Revenue Market Share by Country (2016-2027) Figure 38. Europe Biosimilar Drug Sales Market Share by Type (2016-2021) Figure 39. Europe Biosimilar Drug Sales Market Share by Application (2016-2021) Figure 40. Latin America Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million) Figure 41. Latin America Biosimilar Drug Sales Market Share by Country (2016-2027) Figure 42. Latin America Biosimilar Drug Revenue Market Share by Country (2016-2021) Figure 43. Latin America Biosimilar Drug Sales Market Share by Type (2016-2021) Figure 44. Latin America Biosimilar Drug Sales Market Share by Application (2016-2021) Figure 45. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million) Figure 46. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2016-2027) Figure 47. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2016-2027) Figure 48. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2016-2021) Figure 49. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2016-2021) Figure 50. Biosimilar Drug Supply Chain (Upstream and Downstream Market) Figure 51. Global Production Market Share of Biosimilar Drug Raw Materials by Region in 2020 Figure 52. Biosimilar Drug Distribution Channels Figure 53. Global Biosimilar Drug Percentage 2016-2027: Indirect Sales VS Direct Sales Figure 54. Global Biosimilar Drug Percentage 2016-2027: Online Sales VS Offline Sales Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us